Stock SILCOPHL SILCO PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Silco Pharmaceuticals Limited

Equities

SILCOPHL

BD0495SILCO6

End-of-day quote Dhaka S.E.
Other stock markets
 06:00:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
19.2 BDT +1.59% Intraday chart for Silco Pharmaceuticals Limited -4.48% -17.95%
May. 01 Silco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
Feb. 07 Silco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Silco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024
CI
Silco Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
CI
Silco Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2023
CI
Silco Pharmaceuticals Limited Recommends Cash Dividend for All Shareholders Excluding Directors for the Year Ended June 30, 2023
CI
Silco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
CI
Silco Pharmaceuticals Limited Approves Cash Dividend for the Year Ended June 30, 2022
CI
Silco Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended June 30, 2022
CI
37,316,700 Ordinary Shares of Silco Pharmaceuticals Limited are subject to a Lock-Up Agreement Ending on 11-FEB-2022.
CI
Silco Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended on June 30, 2021
CI
Silco Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended on June 30, 2020
CI
Silco Pharmaceuticals Limited Reports Earnings Results for the Year Ended on June 30, 2020
CI
Silco Pharmaceuticals Limited Signs First Export Agreement with Zaid Elyas Adil Ltd
CI
27,053,300 Ordinary Shares of Silco Pharmaceuticals Limited are subject to a Lock-Up Agreement Ending on 11-FEB-2020.
CI
Silco Pharmaceuticals Limited Recommends Dividend for the Year Ended June 30, 2019
CI
Silco Pharmaceuticals Limited Announces Earnings Results for the Third Quarter and Nine Months Ended Period Ended on 31 March 2019
CI
Silco Pharmaceuticals Limited has completed an IPO in the amount of BDT 300 million.
CI
Silco Pharmaceuticals Limited has filed an IPO in the amount of BDT 300 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SILCOPHL Stock
  4. News Silco Pharmaceuticals Limited
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW